O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2020ACC: 0001209191-20-040294
Officer· Chief Medical Officer
Since Jun 2018
+52.00
Net shares
Net buyer
$935.74
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
52.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+26.00
Price / share
$35.99
Trade value
$935.74
% of position
1.3%
6/30/2020
2.05K→2.07K
Total
Net shares
+26.00
Net value
$935.74
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | A · Award | +26.00 | $35.99 | $935.74 | 1.3% | 2.05K | 2.07K |
| Total | +26.00 | $935.74 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
26.00 shares
Shares
+26.00
Strike price
42.34
Held after
26.00
Exercisable
—
6/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock26.00 shares | 6/30/2020 | A · Award | +26.00 | 42.34 | — | 26.00 |